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Abstract
Objectives Numerous receptors have been implicated in
recognition of pathogenic fungi by macrophages, including
the b-glucan receptor dectin-1. The role of scavenger
receptors (SRs) in anti-fungal immunity is not well
characterized.
Methods We studied uptake of unopsonized Saccharo-
mycetes cerevisiae (zymosan) and live Candida albicans
yeasts as well as zymosan-stimulated H2O2 production in
J774 macrophage-like cells and peritoneal exudate mac-
rophages (PEMs). The role of different receptors was
assessed with the use of competitive ligands, transfected
cells and receptor-deﬁcient macrophages.
Results The uptake of zymosan by untreated J774 cells
was mediated approximately half by SRs and half by a
b-glucan receptor which was distinct from dectin-1 and not
linked to stimulation of H2O2 production. Ligands of
b-glucan receptors and of SRs also inhibited uptake of
C. albicans by macrophages (J774 cells and PEMs). In
macrophages pretreated with a CpG motif-containing oli-
godeoxynucleotide (CpG-ODN) the relative contribution
of SRs to yeast uptake increased and that of b-glucan
receptors decreased. Whereas the class A SR MARCO
participated in the uptake of both zymosan and C. albicans
by CpG-ODN-pretreated, but not untreated macrophages,
the related receptor SR-A/CD204 was involved in the
uptake of zymosan, but not of C. albicans. The reduction of
zymosan-stimulated H2O2 production observed in DS-
pretreated J774 cells and in class A SRs-deﬁcient PEMs
suggest that class A SRs mediate part of this process.
Conclusions Our results revealed that SRs belong to a
redundant system of receptors for yeasts. Binding of yeasts
to different receptors in resting versus CpG-ODN-pre-
exposed macrophages may differentially affect polarization
of adaptive immune responses.
Keywords MARCO  CD204  Oxidative burst
Introduction
Despite the availability of new anti-fungal drugs, infections
caused by pathogenic fungi continue to constitute a serious
medical problem. In particular, Candida albicans,a n
opportunistic fungal pathogen, is a major cause of
morbidity and mortality among immunocompromised
individuals [1]. Several studies have demonstrated the key
roles of neutrophils and activated macrophages in con-
trolling systemic and mucosal C. albicans infections [2, 3].
These phagocytic cells utilize a diverse array of opsonin-
dependent and -independent mechanisms to recognize
C. albicans. Opsonin-independent mechanisms may be
particularly important in the initial, critical phases of
infection and in certain anatomical locations, such as the
lung, in which opsonin levels are low.
Numerous receptors have been implicated in opsonin-
independent recognition of C. albicans by innate immune
cells, which reﬂects the complex structure of the cell wall of
this eukaryotic organism, composed of chitin, b-glucans,
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123different mannoproteins and glycolipids. Zymosan, a
preparation of baker’s yeasts (Saccharomycetes cerevisiae),
is frequently used as a model particle in studies on the
interactions between macrophages and yeasts. Receptors
implicated in opsonin-independent recognition of C. albi-
cans or of zymosan include complement receptor 3 (CR3,
aMb2 integrin, CD11b/CD18) [4–6] and dectin-1 [7], which
bind cell wall b-glucans; mannose receptor [8], DC-SIGN,
and its murine homologue, SIGNR1 [9, 10], TLR2 [11],
TLR4 [11, 12], CD14 [12], and galectin-3 [13], which
bind mannans or other mannose-containing compounds.
Involvement of some of these receptors in yeast recognition
is controversial. For instance, Brown, Taylor et al. [14, 15]
reported that opsonin-independent zymosan binding was
unaffected by genetic CR3 deﬁciency or a blocking mAb
against CR3, suggesting that CR3 was not the receptor
mediating this activity. Also mannose receptor-deﬁcient
macrophages exhibited no defect in the phagocytic uptake
of C. albicans, as well as resistance to C. albicans infection
was unimpaired in mannose receptor-deﬁcient mice [16].
There is evidence that opsonin-independent recognition
of yeasts and zymosan by macrophages is mediated largely
by dectin-1 [14, 17–19]. In different populations of mouse
macrophages, zymosan binding was inhibited by anti-
dectin-1 mAb by as much as 50–80% [10, 14, 15]. The anti-
dectin-1 mAb produced similar inhibition of zymosan
binding as b-glucans, leading the authors to conclude that
dectin-1 was the sole b-glucan receptor on macrophages
[10,14,15].Non-redundant function ofdectin-1 inb-glucan
recognition seemed to be conﬁrmed by the effects of dectin-
1 deﬁciency in mice. Taylor et al. [19] reported that in
comparison with wild-type controls, thioglycollate-elicited
peritoneal macrophages (PEMs) from dectin-1-deﬁcient
mice exhibited strongly decreased uptake (*70–80%
reduction) of unopsonized zymosan and of C. albicans
yeasts. Dectin-1 and TLR2 synergistically mediated zymo-
san- or live yeast-stimulated IL-12p40 and TNF-a
production in macrophages [19–21]. However, other ﬁnd-
ings suggested that stimulation of TNF-a and IL-12
production by b-glucans and of IL-10 by zymosan depended
mainlyondectin-1ratherthanonTLR2[18,22,23].Dectin-
1 seemed to mediate also most of zymosan- or C. albicans
yeast-stimulated oxidative burst [17,19,21] and leukotriene
release from macrophages [24], independent of TLR2.
However, recognition of C. albicans and other fungi by
macrophages seems to be a more complex process than is
suggested by the above reports and may involve other
receptors, in addition to dectin-1. For instance, dectin-1
interact with neither ﬁlamentous morphogens of C. albi-
cans (hyphae and pseudohyphae) [17] nor primarily
pathogenic fungi [25], which do not express b-glucans on
their surface. Moreover, the aforementioned results of
Taylor et al. [19] are contradicted by those of Saijo et al.
[18] who reported that PEMs from dectin-1-knockout mice
bound C. albicans yeasts as efﬁciently as PEMs from wild-
type mice. Netea et al. [26] reported that C. albicans-
stimulated cytokine production in monocytes/macrophages
is mediated by three recognition systems, each of which
sensing speciﬁc components of the C. albicans cell wall: by
the mannose receptor which binds N-linked mannosyl
residues in mannoproteins, by TLR4 which binds O-linked
mannosyl residues and, to a lesser extent, by a b-glucan
receptor. Yet another receptor, galectin-3, has been sug-
gested to mediate discrimination between C. albicans and
S. cerevisiae yeasts, by binding to b-1,2-mannosides,
which are expressed on the surface of C. albicans but not
on S. cerevisiae [13].
The class A scavenger receptors, SR-A and MARCO,
fulﬁll an important role in antibacterial host defense, as
indicated by their ability to mediate phagocytosis of both
Gram-positive and Gram-negative bacteria [27, 28] and by
the decreased resistance to bacterial infections in mice
deﬁcient in these receptors [28–30]. Scavenger receptors
were not originally considered to be involved in anti-fungal
defense [27]; however, later work indicated that this pre-
sumption was incorrect [31, 32]. For example, Bin et al.
[31] reported that MARCO mediated phagocytosis of
yeasts opsonized with uteroglobulin-related protein 1 and
other reports suggested that receptors with SR features
might be involved in direct (opsonin-independent) recog-
nition of major constituents of fungal cell walls. Dushkin
et al. [33] and Vereschagin et al. [34] reported that car-
boxymethylated glucans were bound to mouse peritoneal
macrophages via SRs. It was subsequently reported that
glucans bound to two types of receptors with the features of
SRs (e.g., binding acetylated low density lipoproteins and
polyinosinic acid, but not polycytidylic acid) in membranes
isolated from human promonocytic U937 cells. While
glucan phosphate bound to both receptors, carboxymethy-
lated glucans and a neutral b-glucan, laminarin, interacted
with only one of these binding sites [35]. Zymosan was
found to be a ligand of scavenger receptor with C-type
lectin domain (SR-CL), a receptor structurally similar to
SR-A. Like SR-A, SR-CL contains coiled-coil and col-
lagenous domains, but the terminal scavenger receptor
cysteine-rich domain (SRCR) present in SR-A is replaced
by the C-type lectin domain in SR-CL. Zymosan binding to
SR-CL was mediated by its collagenous domain and
inhibited by polyanionic ligands of SRs [36]. When this
paper was in preparation, Wang and Chandawarkar [37]
reported that transfection with SR-A conferred on CHO
cells the ability to bind zymosan.
In the presented study we have undertaken a compre-
hensive analysis of murine macrophage receptors involved
in the uptake of zymosan and live C. albicans yeasts, and in
zymosan-stimulated H2O2 production.
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123Materials and methods
Reagents
Rat anti-mouse SR-A 2F8 mAb, anti-MARCO ED31 mAb
and anti-dectin-1 2A11 mAb were purchased from Serotec
(Oxford, UK). Rat anti-mouse CD11b mAb (clone M1/70);
and the control mAbs, rat IgG2b (clone A95-1) and IgG1
(clone R3-34) were purchased from PharMingen (San
Diego, CA). Horse radish peroxidase (HRP)-conjugated
F(ab’)2 fragment of goat anti-rat IgG antibody was from
Rockland (Gilbertsville, PA). Alexa Fluor 488-labeled
zymosan, BODIPY-labeled Staphylococcus aureus biopar-
ticles, and carboxyl-modiﬁed 1 lm ﬂuorescent (green)
polystyrene spheres were from Molecular Probes (Eugene,
OR). Nuclease-resistant phosphorothioate oligonuleotide
1826, containing two mouse-optimized immunostimulatory
CpGmotifs(CpG-ODN:TCCATGACGTTCCTGACGTT)
wasobtainedfromColeyPharmaceuticalGroup(Wellesley,
MA) and recombinant mouse IFN-c from R&D Systems
(Minneapolis, MN). All chemical reagents not otherwise
speciﬁed were obtained from Sigma Chemical Co. (St.
Louis, MO).
Cells
Candida albicans yeasts expressing green ﬂuorescent
protein (GFP) were kindly donated by Dr. Cheryl A. Gale
(University of Minnesota, Minneapolis, MN). Yeasts were
maintained on YPD agar (Difco, Detroit, MI) in sterile
Petri dishes at 4C. Before the experiments, yeast cells
were transferred onto fresh YPD agar and incubated for
2 days at room temperature. Just before use in experiments,
yeast cells were recovered, washed with sterile PBS, re-
suspended with a small volume of PBS, counted, and
adjusted to an appropriate density with medium.
The culture of J774A.1 macrophage-like cells was
maintained in FCS-RPMI medium [RPMI-1640 medium
with 25 mM HEPES, supplemented with 10% FCS (Gemini
Bio-Products, Woodland, CA), 2 mM L-glutamine, and
antibiotics], in unmodiﬁed polystyrene (bacteriological
grade) 6-well plates. The medium was replaced every
2–3 days. Cells, which adhere loosely under these condi-
tions, were detached by pipetting, re-suspended in fresh
medium (with or without 10 lg/ml CpG-ODN or 20 ng/ml
IFN-c) and plated at 1 9 10
5/well in 96-well tissue culture
plates, 1 day before use in experiments.
MARCO-deﬁcient mice, developed by Soininen [30],
and SR-A-deﬁcient mice [29], both on a C57BL/6 back-
ground, were maintained in our facility under pathogen-
free conditions. Mice deﬁcient in both SR-A and MARCO
(dKO) were obtained by cross-breeding the single knock-
outs, as described previously [38]. C57BL/6 and Balb/c
mice were purchased from Charles River Labs (Wilming-
ton, MA). Female mice, 9–14 weeks old, were used in the
experiments. All procedures and animal protocols used in
this study were approved by an appropriate institutional
review committee. Mice were euthanized by inhalation
of halothane (Halocarbon Labs, River Edge, NJ). Inﬂam-
matory peritoneal cells, elicited with 1 ml of aged, 3%
thioglycollate (Difco), injected i.p. 4–5 days prior to
euthanasia, were extracted into centrifuge tubes kept on ice,
washed with PBS, and re-suspended in FCS-RPMI medium.
These were then plated at 1.6 9 10
5/well in 96-well tissue
culture plates. After overnight incubation, with or without
10 lg/ml CpG-ODN, non-adherent cells were removed by
washing, and adherent macrophages (peritoneal exudate
macrophages, PEMs) were used in the experiments descri-
bed below.
Transfection of CHO-K1 cells
CHO-K1 cells were grown in Ham’s F12 medium (Me-
diatech, Herndon, VA) supplemented with 10% FCS and
20 lg/ml gentamicin. Expression vectors containing full
length or truncated versions of human MARCO were kindly
provided by Dr. Karl Tryggvason (Karolinska Institute,
Sweden). MARCO was transiently transfected into CHO-
K1 cells using FuGENE6 (Roche, Indianapolis, IN),
according to the manufacturer’s instructions. Brieﬂy, cells
were washed with Ham’s F-12/10% FCS (without antibi-
otics) while DNA/transfection reagent mix was prepared
by mixing FuGENE6 and cDNA at a 9:2 ratio (ll Fu-
GENE6:lg cDNA) in serum-free medium. The DNA mix
was then added to the cells, which were cultured overnight
before binding assays were performed.
Receptor expression
Expression of SR-A, MARCO, CR3 and dectin-1 on
adherent J774 cells was assessed by cellular ELISA, as
described previously [39]. The culture medium was
replaced with 50 ll of 20% mouse serum in FCS-RPMI
medium and the plate placed on ice for 10 min pre-incu-
bation. Cells were subsequently incubated for 40 min on
ice with receptor-speciﬁc mAbs or the same concentrations
of isotype-matched control mAbs in 100 ll of 20% mouse
serum [10 (A95-1, 2A11, 2F8, M1/70) or 25 (R3-34,
ED31) lg/ml]. Unbound mAbs were removed by washing
the wells three times with ice-cold HBSS, adherent cells
were then incubated for another 40 min with 5 lg/ml of
HRP-conjugated F(ab’)2 fragment of goat anti-rat IgG
antibody in 20% mouse serum. Wells were washed ﬁve
times with HBSS and 0.1 ml of TMB (Dako, Carpinteria,
CA), the HRP substrate, was added to each well. The
reaction was stopped with 0.1 ml of 2 M H2SO4 and
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570 nm, was measured in a plate reader.
Phagocytic assay
Monolayers of adherent J774 cells, CHO cells, or PEMs in
96-well plates were pre-incubated for 20 min at room
temperature with 50 ll of double-concentrated solutions of
receptor-speciﬁc or isotype-matched control mAbs (ﬁnal
concentrations: ED31—25 lg/ml, 2A11—20 lg/ml, 2F8
and M1/70—10 lg/ml), DS, CS, mannan, laminarin (ﬁnal
concentration 400 lg/ml) or CpG-ODN (200 lg/ml).
Suspensions of latex beads (100 lg/ml), BODIPY-S. aur-
eus (25 lg/ml), or Alexa Fluor 488-zymosan (50 lg/ml)
ﬂuorescent particles were added in 50 ll of the medium
and allowed to be phagocytosed for 1.5 h at 37C. Incu-
bation with C. albicans yeasts (2 9 10
6/well) was
performed for 40 min only to prevent the formation of
germ tubes, which occurs during longer incubations. The
wells were washed four times with HBSS and ﬂuorescence
of bound/ingested particles was measured in a ﬂuorescence
plate reader (Spectraﬂuor Plus, Tecan, Research Triangle
Park, NC). In experiments comparing different cell popu-
lations, ﬂuorescence values were corrected for slight
differences in numbers of adherent cells, determined on the
basis of lactic dehydrogenase activity in lysates of adherent
cells, as described previously [40].
H2O2 assay
Hydrogen peroxide production was assayed by spectroﬂu-
orimetric monitoring of H2O2-mediated, HRP-catalyzed
oxidation of nonﬂuorescent Amplex Red reagent (Molec-
ular Probes) into ﬂuorescent resoruﬁn, as described
previously [40]. Adherent PEMs or J774 cells in 96-well
plates were pre-incubated for 20 min at room temperature
with DS or laminarin (400 lg/ml) and then stimulated with
zymosan (50 lg/ml) in 0.1 ml HBSS, containing 50 lM
Amplex Red and 1 U/ml of HRP. Fluorescence (535/
595 nm) was measured for 40 min every 5 min, beginning
4 min after placing a plate in the ﬂuorescence plate reader,
pre-warmed to 37C. Fluorescence is directly proportional
to H2O2 concentration [40], thus the data are presented as
the difference between ﬂuorescence at the beginning and
the end of the measurement.
Data analysis
All experiments were performed in 4–5 replicates and
results are presented as mean ± SEM from either several,
independent experiments or from replicates obtained in a
single, representative experiment. Means were compared
with Student’s t test for single comparisons, or with
ANOVA for multiple comparisons (GraphPad Prism soft-
ware, San Diego, CA). P values\0.05 were considered to
be statistically signiﬁcant.
Results
Zymosan uptake by J774 cells is mediated by SRs
and by a b-glucan receptor(s) distinct from dectin-1
Because dectin-1 has been reported to be the dominant
zymosan and C. albicans yeasts receptor in murine mac-
rophages, and therefore may mask involvement of other
receptors, we performed initial studies in macrophage-like
J774 cells, which express low levels of dectin-1 [41]. The
b-glucan, laminarin, inhibited uptake of Alexa Fluor
488-labeled zymosan by J774 cells by 45 ± 4.7%, while
the general polyanionic inhibitor of SRs, dextran sulfate
(DS), reduced zymosan uptake by 50 ± 9.8%, and a
combination of these ligands reduced zymosan uptake
almost completely (90 ± 1.7%). At the concentration used
(0.4 mg/ml) laminarin and DS exerted already maximal
inhibition as no further inhibition was produced by
increasing their concentration (to 0.8 mg/ml). In contrast,
zymosan uptake was not affected by the a-glucan, dextran,
or by the control polyanion chondroitin sulfate (CS), which
does not bind to SRs (Fig. 1a). The additive effect of the
combination of DS and laminarin on zymosan uptake
suggests that receptors that bind laminarin and those that
bind DS are different receptors. Uptake of zymosan was
also unaffected by mannan (Fig. 1a), suggesting that
receptors that bind mannan, such as the mannose receptor
[8], SIGNR1 [10] and galectin-3 [13], do not participate in
zymosan uptake by J774 cells.
Experiments using blocking mAbs speciﬁc for SR-A
(targeted by 2F8 mAb) or MARCO (targeted by ED31
mAb) indicate that SR-A, but not MARCO, contributes to
uptake of zymosan in untreated J774 cells (Fig. 1b).
Zymosan uptake in J774 cells was also inhibited signiﬁ-
cantly by anti-CR3 mAb, M1/70 (Fig. 1b). M1/70 mAb
blocks ligand binding to the lectin-like binding site on the
CR3 molecule, which has been implicated in binding to
unopsonized zymosan [6]. Finally, consistent with the
original description of dectin-1 as a receptor expressed at
the mRNA level in dendritic cells but not J774 cells [41],
dectin-1 was very weakly expressed on J774 cells (Fig. 1c),
and not signiﬁcantly involved in zymosan uptake, as
indicated by the lack of an effect of anti-dectin-1 mAb,
2A11 (Fig. 1b).
Because the zymosan uptake assay was performed in
media containing serum, there was a possibility that
opsonization by serum components was responsible for
zymosan binding to SR-A or CR3. To establish the impact
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123of serum on the results of the previous experiments,
zymosan uptake in serum-free and serum-containing
medium was determined. The presence of serum had no
major effect on both the magnitude and the receptor
speciﬁcity of zymosan uptake (Fig. 1d).
Zymosan uptake by b-glucan receptor(s) in J774 cells
pre-treated with CpG-ODN is decreased
while that by SRs is increased
Pre-treatment with CpG-ODN has been reported to
enhance opsonin-independent phagocytosis in macro-
phages, largely as a result of up-regulation of SRs [39, 42].
Pre-treatment with CpG-ODN increased zymosan uptake
by J774 cells by 47 ± 13.4% (N = 8, p = 0.01) over cells
with no pre-treatment (Fig. 1a), with different receptors
contributing differently to the overall increase in zymosan
uptake. In CpG-ODN-pretreated cells, DS alone inhibited
zymosan uptake to a similar degree as the combination of
DS and laminarin in untreated cells (83 ± 2.3%), whereas
laminarin had no effect on zymosan uptake (Fig. 1a).
These results indicate that SRs mediate the CpG-ODN-
induced increase in zymosan uptake by J774 cells, com-
pensating in excess decreased uptake through b-glucan
receptors.
A more detailed analysis using mAbs revealed that the
CpG-ODN-induced increase in zymosan uptake by J774
cells may be ascribed largely to MARCO; there was a
Fig. 1 Receptor speciﬁcity of zymosan uptake by untreated and
CpG-ODN-pretreated J774 cells. a Untreated or CpG-ODN pre-
treated J774 cells were pre-incubated for 20 min at room temperature
with 50 ll of 0.8 mg/ml dextran sulfate (DS), chondroitin sulfate
(CS), laminarin (LAM), dextran (DEX), mannan (MAN) or a
combination of DS and LAM (0.4 mg/ml each). Subsequently, a
suspension of Alexa Fluor 488-labeled zymosan was added in 50 ll
(ﬁnal concentration 50 lg/ml) and allowed to be phagocytosed for
1.5 h at 37C. The wells were washed extensively and ﬂuorescence of
bound/ingested zymosan was measured in a ﬂuorescence plate reader.
b Effects of anti-MARCO (25 lg/ml), anti-SR-A (10 lg/ml), anti-
CR3 (10 lg/ml), or anti-dectin-1 (20 lg/ml) monoclonal antibodies,
relative to effects of the same concentrations of isotype-matched
control antibodies (cIgG), on zymosan uptake by untreated or CpG-
ODN pre-treated J774 cells. Cells were pre-incubated with indicated
antibodies and the zymosan uptake assay was performed as described
above. c Expression of MARCO, SR-A, CR3 and dectin-1 on
untreated or CpG-ODN pre-treated J774 cells which was assessed by
cellular ELISA. Receptor-speciﬁc binding was calculated by subtract-
ing the binding of isotype-matched control antibodies from the
binding of receptor-speciﬁc antibodies. d Effects of indicated mAbs
on zymosan uptake by untreated J774 cells in serum-free and serum-
containing media (FCS-RPMI). Data show mean (?SEM) results from
indicated number (N) of independent experiments (a, b) or results of
single experiments, each representative of two such experiments
performed (c, d). Hash symbol Signiﬁcantly different from untreated
controls (P\0.05 in one-sample t test); Double hash symbol
signiﬁcantly different from both LAM and DS group (P\0.05 in
two-tailed t test); ﬁlled star signiﬁcantly different from CpG-ODN-
pretreated controls (P\0.05 in two-tailed t test); ND not done
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uptake by the anti-MARCO mAb, ED31 in these cells
(Fig. 1b). Consistent with the inhibition of zymosan uptake
by anti-MARCO mAb in CpG-ODN-pretreated J774 cells,
these cells exhibited strongly increased levels of MARCO
expression compared to untreated J774 controls (Fig. 1c),
as previously reported [39]. In contrast, pre-treatment with
CpG-ODN affected neither SR-A expression (Fig. 1c) nor
the ability of anti-SR-A mAb to inhibit zymosan uptake
(Fig. 1b). Although the CpG-ODN pre-treatment increased
CR3 involvement in zymosan uptake, indicated by
increased inhibitory potency of the CR3-speciﬁc mAb,
M1/70 (29 ± 2.8 vs. 50 ± 8.4% inhibition, Fig. 1b), there
was slightly decreased CR3 expression on CpG-ODN
pre-treated J774 cells (Fig. 1c).
SR-A or MARCO deﬁciency has little impact
on zymosan uptake
We also assessed the role of class A SRs in zymosan
uptake with the use of PEMs deﬁcient with these receptors.
The uptake of zymosan was not signiﬁcantly decreased in
MARCO-/- or SR-A-/- PEMs (Fig. 2a). However,
CpG-ODN-pretreated MARCO-deﬁcient PEMs exhibited
slightly (by *12%), but signiﬁcantly decreased zymosan
uptake in comparison to CpG-ODN-pretreated wild-type
PEMs (Fig. 2a). Similarly as in J774 cells (Fig. 1b), anti-
MARCO antibody inhibited zymosan uptake in CpG-
ODN-pretreated, but not in untreated wild-type PEMs
(Fig. 2b). Weaker effects of receptor deﬁciencies as com-
pared to receptor-speciﬁc blocking antibodies might be
caused by compensatory up-regulation of alternative
receptors in knockout macrophages. Indeed, we reported
previously that SR-A-/- PEMs expressed increased level
of MARCO [39]. Because C57BL/6 strain of mice (the
parent strain of knockout mice) express an allelic isoform
of SR-A which is not recognized by the available anti-SR-
A antibody 2F8 [43] we could not assess whether MARCO
deﬁciency was accompanied by changes in SR-A expres-
sion. Wild-type and MARCO-/- PEMs expressed similar
levels of CR3 (data not shown). In contrast, the absence of
both class A SRs could not be fully compensated by
alternative receptors. PEMs deﬁcient with both SR-A and
MARCO took up slightly, but signiﬁcantly less zymosan
than wild-type controls (by *11%) and this difference was
enhanced in CpG-ODN-pretreated macrophages (*22%)
(Fig. 2c).
Uptake of zymosan and live Candida albicans yeasts
is mediated by overlapping, but not identical sets
of receptors
Both J774 cells (Fig. 3a, b) and PEMs (Fig. 3c) exhibited
robust uptake of green ﬂuorescent protein (GFP)-express-
ing live C. albicans yeasts at 37C. Inspection under
inverted microscope revealed that the majority of C. albi-
cans was trapped inside ‘‘swollen’’ macrophages (data not
shown). J774 cells exhibited negligible binding of yeasts at
4C (Fig. 3a), indicating that low temperature prevents
not only internalization, but also binding of yeasts to
macrophages.
The CpG-ODN pretreatment increased uptake of live
yeast by J774 cells to a similar extent as uptake of
zymosan (by 38 ± 9.0%, N = 6, p = 0.01, Fig. 3a, b).
Similarly, effects of DS and laminarin indicate that live
yeast uptake was mediated largely by b-glucan receptors
in untreated J774 cells and by SRs, but not by b-glucan
receptors, in CpG-ODN pre-treated J774 cells (Fig. 3b). A
Fig. 2 Effect of class A scavenger receptors deﬁciencies (a, c)o r
anti-MARCO mAb (b) on zymosan uptake by peritoneal exudate
macrophages (PEMs). Untreated or CpG-ODN pretreated PEMs,
isolated from wild-type, MARCO-/-, SR-A-/- or SR-A-/-
MARCO-/- (dKO) mice, were pre-incubated (b) or not (a, c) with
anti-MARCO mAb or the same concentration of isotype-matched
control IgG1 and then co-incubated with 50 lg/ml zymosan
suspension for 1.5 h. Following thorough washing, ﬂuorescence of
bound/ingested particles was measured in a ﬂuorescent plate reader.
Graphs show mean values ?SEM of four replicates, obtained in
single experiments, each representative of at least three such
experiments performed. Filled star signiﬁcant effect of receptor
deﬁciency or anti-MARCO mAb (P\0.05 in two-tailed t test)
118 S. Jo ´zefowski et al.
123control polyanion, CS, had no effect on yeast uptake (data
not shown). However, results of experiments with the use
of other competitive receptor ligands indicate that recep-
tor speciﬁcities of zymosan and live yeasts in J774
macrophages are not identical. In particular, anti-SR-A
and anti-CR3 mAbs, which inhibited zymosan uptake by
untreated J774 cells (by 28 ± 3.4% and 29 ± 2.8%,
respectively, Fig. 1b) had no signiﬁcant effect on live
yeast uptake (data not shown). The lack of SR-A
involvement in yeast uptake may explain the reduced
ability of DS to inhibit live yeast uptake (24 ± 5.6%
inhibition, N = 4, p = 0.02, Fig. 3b) as compared to
zymosan uptake (50 ± 9.8% inhibition, N = 5,
p = 0.007, Fig. 1a) in untreated J774 cells.
The receptor speciﬁcity of yeast uptake by PEMs was
also assessed. For these studies PEMs from Balb/c mice
were used because of the above mentioned inability of 2F8
mAb to bind to an allelic isoform of SR-A which is
expressed in C57BL/6 mice [43]. As with J774 cells,
uptake of C. albicans by PEMs from Balb/c mice was
inhibited by laminarin and by DS, but not by anti-SR-A
mAb (Fig. 3d). C. albicans uptake by PEMs from Balb/c
mice was also signiﬁcantly inhibited by anti-dectin-1 mAb
(Fig. 3d). Both laminarin and anti-dectin-1 mAb exhibited
decreased ability to inhibit yeast uptake in CpG-ODN-pre-
treated PEMs. Conversely, anti-CR3 mAb slightly inhib-
ited yeast uptake in CpG-ODN-pretreated, but not
untreated PEMs. Mannan did not affect yeast uptake by
Fig. 3 Receptor speciﬁcities of live Candida albicans yeasts uptake
by J774 cells and PEMs. a Untreated or CpG-ODN pre-treated J774
cells were co-incubated with C. albicans yeasts for 40 min at 4 or
37C, washed four times and ﬂuorescence of J774 cells-associated
yeasts was measured. b, c Effect of laminarin (LAM) and dextran
sulfate (DS) on C. albicans yeasts uptake by untreated or CpG-ODN
pre-treated J774 cells (b) or wild-type or SRA-/-MARCO-/-
PEMs (c). Macrophages were pre-incubated for 20 min at room
temperature with LAM or DS and the yeast uptake assay was
performed at 37C as described above. d Receptor speciﬁcity of
yeasts uptake by untreated or CpG-ODN pre-treated Balb/c PEMs.
Adherent macrophages were pre-incubated with the indicated ligands
for 20 min at room temperature before the phagocytic assay was
performed in the continuous presence of these ligands. Graphs (a–
c) show results of single experiments, each representative of 2–4 such
experiments performed. Data on graph (d) are expressed as % of
controls (no competitor or isotype-matched control IgG) and are
means ?SEM from 3 to 7 independent experiments. Filled star
signiﬁcantly different (P\0.05 in two-tailed t test) from the
respective control (no competitor or isotype-matched control IgG);
Hash symbol signiﬁcant effect of the CpG-ODN pre-treatment
(P\0.05 in two-tailed t test); ND not done
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(data not shown).
Binding of yeasts to MARCO is mediated by a novel
binding site
Neither SR-A nor MARCO deﬁciency had a consistent
effect on yeast uptake by PEMs (data not shown). How-
ever, a difference between wild-type and MARCO-
deﬁcient strains of macrophages became apparent after
CpG-ODN pre-treatment. On average from several exper-
iments, the CpG-ODN pretreatment had no signiﬁcant
effect on C. albicans uptake by PEMs from wild-type
C57BL/6 mice (in individual experiments the effect ranged
from slight enhancement to slight inhibition), but signiﬁ-
cantly decreased yeast uptake by PEMs from MARCO-
deﬁcient C57BL/6 mice (Fig. 4a). However, although the
magnitude of yeast uptake in CpG-ODN-pretreated PEMs
from wild-type C57BL/6 mice did not change, the contri-
bution of non-b-glucan receptors to yeast uptake increased,
while the contribution of b-glucan receptors decreased.
This is indicated by the decreased ability of laminarin to
inhibit yeast uptake in CpG-ODN-pretreated as compared
to untreated C57BL/6 PEMs (Fig. 4b). In regard to uptake
of live yeast, the above results indicate that down-regula-
tion of b-glucan receptors in CpG-ODN-pretreated wild-
type C57BL/6 PEMs is compensated by up-regulation of
other receptors which seem to include MARCO.
Fig. 4 Role of MARCO as a receptor for C. albicans yeasts. a The
effect of CpG-ODN pre-treatment on yeasts uptake by Balb/c, wild-
type or MARCO-deﬁcient C57BL/6 PEMs. b Uptake of yeasts by
untreated or CpG-ODN pre-treated wild-type PEMs, in the presence
or absence of 0.4 mg/ml laminarin. c Uptake of yeasts by CHO cells
transfected with human MARCO (hMARCO). Filled star signiﬁ-
cantly different from respective controls (untreated PEMs or non-
transfected CHO cells) (P\0.05 in one-sample (a) or two-tailed
(b–c) t test). d Uptake of BODIPY-labeled S. aureus, GFP-expressing
C. albicans yeasts or ﬂuorescent polystyrene spheres by CHO cells
transfected with either the full-length human MARCO (MARCOFULL)
or with receptors with the truncated SRCR domain (MARCO442 or
MARCO420). Different symbols above error bars indicate values
signiﬁcantly different from one another (P\0.05, ANOVA). Data on
graph (a) are expressed as % of untreated controls and are means
?SEM from indicated number (N) of independent experiments.
Graphs (b–d) show results of single experiments, performed in 4–5
replicates, each representative of three such experiments performed
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123Interestingly, the effect of CpG-ODN pre-treatment on
yeast uptake by Balb/c PEMs resembled that seen in
MARCO-/- PEMs, although, due to high inter-experi-
mental variability, it did not reach statistical signiﬁcance
(Fig. 4a). Moreover, in contrast to J774 cells (Fig. 3b) and
C57BL/6 PEMs (Fig. 3c), the ability of DS to inhibit yeast
uptake was not increased in CpG-ODN-pretreated PEMs
from Balb/c mice (Fig. 3d). The latter results might be
explained by a limited contribution of MARCO to yeast
uptake by PEMs of the Balb/c strain. Unlike J774 cells and
PEMs from C57BL/6 mice, PEMs from Balb/c mice
express very low or undetectable level of MARCO, which
is only weakly up-regulated by the CpG-ODN pretreatment
[39]. Conﬁrming such an interpretation, pretreatment with
CpG-ODN did not increase potency of DS to inhibit yeast
uptake also in C57BL/6 PEMs deﬁcient with both SR-A
and MARCO (Fig. 3c).
The involvement of MARCO in yeast uptake was con-
ﬁrmed in experiments with transfected cells. CHO cells
transfected with human MARCO exhibited signiﬁcantly
increased binding of yeasts as compared to non-transfected
CHO cells (Fig. 4c). Despite the apparent role of MARCO
in the uptake of live yeast by macrophages, the anti-
MARCO mAb, ED31, did not inhibit uptake of yeasts in
non-treated J774 cells as well as in CpG-ODN-pre-treated
J774 cells (data not shown) or PEMs from Balb/c mice
(Fig. 3d).
The ligand binding site of SR-A is localized in the
collagenous domain of the receptor [44]. In contrast,
although MARCO contains a homologous collagenous
domain, binding of MARCO ligands has been mapped to
the SRCR domain of the receptor [45]. We hypothesized
that the inability of the SRCR-directed anti-MARCO mAb,
ED31, to inhibit yeast binding results from the binding of
yeasts at a distinct binding site, localized outside the SRCR
domain. This hypothesis was tested with the use of CHO
cells transfected with either full-length (MARCOFULL)o r
truncated versions of human MARCO, lacking different
peptide sequences of the SRCR domain. CHO cells trans-
fected with MARCOFULL exhibited increased binding of
yeasts in addition to the established MARCO ligands,
polystyrene spheres and Staphylococcus aureus (Fig. 4d).
In CHO cells transfected with MARCO442 (containing only
ﬁrst 22 residues of the SRCR domain of the receptor),
binding of S. aureus was decreased and that of polystyrene
spheres abolished entirely. CHO cells transfected with
Fig. 5 Hydrogen peroxide production in untreated or CpG-ODN
pre-treated macrophages exposed to dextran sulfate (DS), laminarin
(LAM), anti-dectin-1 mAb, zymosan (ZYM) or combination of these
ligands. a Effect of LAM or DS on ZYM-stimulated H2O2 production
in untreated or CpG-ODN pre-treated Balb/c PEMs. b Effect of anti-
dectin-1 mAb 2A11 or isotype-matched control IgG2b (cIgG) on
ZYM-stimulated H2O2 production in untreated or CpG-ODN pre-
treated Balb/c PEMs. c Effect of LAM or DS on ZYM-stimulated
H2O2 production in untreated or CpG-ODN pre-treated J774 cells.
d DS- or ZYM-stimulated H2O2 production by wild-type,
MARCO-/-, SR-A-/- or MARCO-/-SR-A-/- PEMs. Graphs
(a–c) show result of single experiments (mean ? SEM), performed
once (b) or representative of three such experiments performed (a and
c). Results on graph (d) are means ? SEM from 3 to 5 independent
experiments. Asterisk symbol signiﬁcantly different from the zymosan
only (a and c) or zymosan plus cIgG-stimulated (b) controls
(P\0.05 in two-tailed t test); Hash symbol signiﬁcant effect of
receptor deﬁciency (P\0.05 in one-way ANOVA)
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neither S. aureus nor polystyrene spheres. In contrast, there
was an increase in yeast binding to CHO cells transfected
with both forms of truncated MARCO receptors (Fig. 4d).
Different receptors mediate zymosan-stimulated H2O2
production in PEMs and J774 cells
The zymosan-stimulated oxidative burst in murine macro-
phages has been shown to be mediated by dectin-1 and
blocked by laminarin [19, 21]. Conﬁrming these reports,
laminarin inhibited by 54 ± 7.4% (average from four
experiments) zymosan-stimulated H2O2 production by
Balb/c PEMs (Fig. 5a). There was a reduction in zymosan-
stimulated oxidative burst in CpG-ODN-pretreated PEMs
compared to untreated PEMs (Fig. 5a, b), which may be
related to down-regulated dectin-1 expression/function
(Figs. 1c, 3d), and as reported previously for ligands of
other TLRs [46]. This hypothesis was conﬁrmed in two out
of three experiments in which laminarin produced no
inhibition of zymosan-stimulated oxidative burst in CpG-
ODN-pre-treated PEMs (Fig. 5a and data not shown). In
one such experiment performed, anti-dectin-1 mAb inhib-
ited most of zymosan-stimulated H2O2 production in
untreated PEMs, but had little effect in CpG-ODN-pre-
treated PEMs (Fig. 5b).
In contrast to PEMs, laminarin produced no inhibition
of zymosan-stimulated oxidative burst in J774 cells
(Fig. 5c). These results provide further evidence that a
yeast-binding b-glucan receptor(s) in J774 cells is distinct
from dectin-1.
Zymosan-stimulated H2O2 production was signiﬁcantly
decreased in PEMs from mice lacking both SR-A and
MARCO (Fig. 5d) suggesting that class A SRs may
mediate part of this response. While DS inhibited zymo-
san-stimulated H2O2 production in J774 cells (more
strongly in CpG-ODN-pre-treated than in untreated cells;
Fig. 5c) but not in Balb/c PEMs (Fig. 5a), DS alone
stimulated signiﬁcant H2O2 production in PEMs from
C57BL/6 (Fig. 5d) and Balb/c mice (data not shown), but
not in J774 cells (Fig. 5c). Therefore, the lack of inhibi-
tion of zymosan-stimulated H2O2 production by DS in
PEMs may be a net effect, resulting from any reduction
of zymosan-stimulated H2O2 production by DS being
compensated for by the signiﬁcant amount of H2O2 pro-
duction induced by DS alone, effects that seem to be
mediated by different receptors. DS alone stimulated
similar H2O2 production in PEMs from wild-type and
from SR-A- or MARCO-deﬁcient mice (Fig. 5d) indicat-
ing a lack of involvement of class A SRs in this process.
Spontaneous or zymosan-stimulated production of H2O2
was not affected by CS in either J774 cells or PEMs (data
not shown).
Discussion
Our experiments revealed that SRs participated in opsonin-
independent uptake of both zymosan and live C. albicans
yeasts by murine macrophages (J774 cells and PEMs).
More speciﬁcally, we have found that SR-A is a receptor
for zymosan, but not live C. albicans yeasts, and that
MARCO contributes to both C. albicans and zymosan
uptake in CpG-ODN-pre-treated macrophages.
Interestingly, the receptors involved in the uptake of
yeasts and the associated biological effects differed by cell
type. For example, a b-glucan receptor, dectin-1, was
partially responsible for yeast uptake in PEMs but not in
J774 cells. Consistent with previous ﬁndings [19, 21],
dectin-1 appeared to be also the major receptor mediating
zymosan-stimulated H2O2 production in PEMs, but in J774
cells, which express very low level of dectin-1, other
receptors substituted for dectin-1 in mediating this
response. We demonstrated that H2O2 production in J774
cells was inhibited by the SRs ligand, DS, but not by the
b-glucan, laminarin. The b-glucan receptor (or receptors)
in J774 cells that does not mediate H2O2 production
remains to be identiﬁed. The inhibition of zymosan-stim-
ulated H2O2 production by DS in J774 cells and the
decreased zymosan-stimulated H2O2 production in PEMs
from MARCO- and SR-A-deﬁcient mice suggest that class
A SRs mediate part of this process. Indeed, we reported
previously that SR-A is able to mediate H2O2 production
upon speciﬁc ligation with mAb [40].
Dextran sulfate produced greater inhibition of zymosan
uptake in untreated J774 cells (*50%) than did anti-SR-A
mAb (*28%), suggesting that SR-A does not fully account
for SRs-mediated zymosan uptake in these cells. Class A
SRs also do not seem exclusively responsible for SRs-
mediated uptake of C. albicans yeasts by PEMs since DS
inhibited C. albicans uptake also in PEMs from SR-A- and
MARCO-deﬁcient mice (by *24%, Fig. 3c). The SRs
responsible for non-class A SR-mediated, DS-inhibitable
binding of zymosan and live yeast in these cells remain to
be identiﬁed. A possible candidate is the scavenger
receptor with C-type lectin domain (SR-CL), as this
receptor is expressed in J774 cells at a high level [47] and
mediates zymosan binding that is inhibited by DS [36].
Recently, two receptors from the SR superfamily, SREC-I
(scavenger receptor expressed by endothelial cells-I) and
CD36, were identiﬁed as receptors for fungal pathogens
[48]. However, it seems unlikely that these receptors had a
major contribution to zymosan or yeast uptake under our
assay conditions because binding of fungi to these recep-
tors was reported to be inhibited by both b-glucans and
classical SR ligands, whereas in our study receptors
inhibited by laminarin and by DS represented distinct,
independently-regulated populations of receptors.
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123Moreover, binding of fungi to SREC-I and CD36 was
partially inhibited by mannan, which had no effect on
C. albicans or zymosan uptake by J774 cells or PEMs in
our study.
We demonstrated that anti-CR3 mAb inhibited zymosan
uptake by J774 cells and C. albicans uptake by CpG-ODN-
pretreated, but not by untreated macrophages. Though it
has been assumed that CR3 is a receptor for zymosan and
more pure b-glucans [4–6], this assumption has been
challenged [14, 15]. Our results suggest that although CR3
does participate in zymosan uptake, it is not a b-glucan
receptor in mouse macrophages because anti-CR3 antibody
inhibited zymosan or yeast uptake under conditions in
which the b-glucan laminarin had no effect, and vice versa
(Figs. 1a, b, 3d). Furthermore, involvement of CR3 in
zymosan or yeast uptake did not correlate with CR3
expression. One possible explanation for this apparent
contradiction is that CR3 does not bind yeast directly, but
cooperates with other yeast-binding receptors which are
up-regulated in CpG-ODN-pretreated macrophages. CR3 is
known to enter into functional cooperation with several
different families of receptors [49]. These CR3 interactions
seem to be mediated by the lectin-like binding site of the
receptor, which is blocked by the mAb, M1/70 [6]. Thus,
anti-CR3 M1/70 mAb might inhibit zymosan and yeast
uptake by preventing cooperation of CR3 with other
receptors which bind yeasts directly.
One major methodological difference between our
studies and those of Brown, Taylor et al. [14, 15] who
demonstrated the lack of CR3 involvement in zymosan
binding, is that we performed the zymosan uptake assay at
37C instead of 4C. The physiological relevance of ligand
binding at 4C is debatable; we observed negligible bind-
ing of yeasts at this temperature. It is possible that this low,
non-physiological temperature may prevent inter-receptor
cooperation or receptor clustering, which may be required
for multivalent, high-afﬁnity binding of yeasts. The ratio-
nale for performing binding assays at 4C was to prevent
zymosan opsonization by complement components
released from macrophages [14, 15]; we found that binding
of zymosan to CR3 and SRs was not mediated by opsonins
present in serum or released from macrophages. Uptake of
zymosan was inhibited by anti-CR3 and anti-SR-A mAbs
to a similar extent in serum-free medium and in serum-
containing medium (Fig. 1d). Moreover, zymosan uptake
by J774 cells was almost completely blocked by a com-
bination of ligands (DS and laminarin, Fig. 1a) that are
unlikely to inhibit complement-, antibody-, or mannose-
binding lectin-mediated phagocytosis.
Recently, we identiﬁed MARCO as one of receptors for
phosphorothioate-modiﬁed oligodeoxynucleotides (ODNs)
[38]. As with yeasts, binding of ODNs to MARCO was not
inhibited by ED31 mAb. Interestingly, in IFN-c-pretreated
J774 cells, which have up-regulated MARCO expression
(data not shown), CpG-ODN at 200 lg/ml inhibited uptake
of yeasts by as much as *52% and zymosan uptake by
*13%, but had no effect on polystyrene sphere uptake
(data not shown). Thus, yeasts and ODNs may share a
novel ligand binding site on MARCO, distinct from the
previously identiﬁed binding site for bacteria and poly-
styrene spheres in the SRCR domain, as suggested by
experiments with truncated receptors (Fig. 4d). The spe-
ciﬁc ligands for SRs on the surface of yeasts remain to be
identiﬁed. Ligands of class A SRs share a common prop-
erty of being negatively charged [44]. In the case of
C. albicans, its surface net negative charge is largely due to
phosphate groups present in the cell wall phosphomannans
and phospholipomannans [50, 51]. Therefore, we hypoth-
esize that the common, speciﬁc ligands for MARCO,
present on the surface of both ODN aggregates and
C. albicans yeasts, may be phosphate groups.
Our another major ﬁnding is that CpG-ODN-induced
macrophage activation, known to be mediated by TLR9,
alters the receptors involved in yeast uptake. When com-
pared to untreated macrophages, CpG-ODN-pretreated
macrophages had reduced b-glucan receptors involvement
in yeast and zymosan uptake and increased SRs involve-
ment. For example, laminarin strongly inhibited zymosan
and yeast uptake in untreated, but not in CpG-ODN-pre-
treated, macrophages. Conversely, anti-MARCO mAb
inhibited zymosan uptake in CpG-ODN-pretreated, but not
in untreated, macrophages. We found that the CpG-ODN-
induced decrease in yeast uptake through b-glucan recep-
tors was fully countered by increased uptake mediated by
non-b-glucan receptors in J774 cells and PEMs from
C57BL/6 mice, but not in PEMs from Balb/c mice.
Because the CpG-ODN pretreatment caused a signiﬁcant
decrease in yeast uptake by PEMs from MARCO-deﬁcient
C57BL/6 mice, this strain-related variability in CpG-ODN
effects on yeast uptake might have resulted from different
effects of the CpG-ODN pretreatment on MARCO
expression. Indeed, the CpG-ODN pretreatment strongly
up-regulated MARCO expression on J774 cells and PEMs
from C57BL/6 mice, but had at most weak effect on the
already much lower basal MARCO expression on PEMs
from Balb/c mice [39].
Different receptors mediating yeast binding in resting
versus activated macrophages are likely to differently
affect macrophage immunoregulatory functions. Both Th1-
type and Th17-type adaptive immune responses have been
implicated in successful host defense against C. albicans
infection and their relative importance in mucosal and
systemic candidiasis is a subject of ongoing debate [52–
54]. Our results are consistent with the possibility that
during fungal infections antigen presenting cells may ini-
tiate Th17-type and Th1-type responses sequentially in,
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which mediates phagocytosis of C. albicans yeasts by
resting macrophages, has been reported to promote dif-
ferentiation of Th17 lymphocytes and to suppress
differentiation of Th1 lymphocytes, probably by inhibiting
production of IL-12 and stimulating production of IL-23,
IL-6 and IL-10 [25, 55, 56]. In later phases of infection,
activation of endosomal TLR9 by DNA liberated from
ingested and degraded C. albicans [57] would result in
down-regulation of dectin-1 and up-regulation of MARCO
expression on antigen presenting cells. MARCO-mediated
interactions of activated antigen presenting cells with
C. albicans would provide a necessary co-stimulatory
signal for a TLR-mediated production of IL-12 [38, 39], a
cytokine crucial for the development of Th1-type adaptive
immune responses.
Itwasreportedthatzymosangeneratedimmunetolerance
in mice [58]. Interestingly, SR-A has been linked to inhibi-
tion of IL-12p70 production [39, 40] and stimulation of
IL-10 secretion [59] and, therefore, might contribute to the
reportedsuppressionofadaptiveimmunitybyzymosan[58].
As shown in this work, SR-A mediates macrophage binding
of zymosan but not intact yeasts. We hypothesize that the
surface of zymosan particles, with exposed b-glucan-rich
inner layers of the yeast cell wall, may mimic products of
fungal cell degradation by phagocytic cells. Consequently,
one of functions fulﬁlled by SR-A might be negative feed-
back regulation of anti-fungal immune responses upon
binding killed yeast debris. Consistent with this proposed
negative regulatory role for SR-A during fungal infections,
SR-A-deﬁcient mice were reported to exhibit enhanced
inﬂammation and elevated numbers of activated CD4? T
cells in the alveoli during lung infection with an opportu-
nistic fungal pathogen, Pneumocystis carinii [32].
In conclusion, our results revealed that SRs and b-glu-
can receptors are two major receptor types involved in
yeast uptake by murine macrophages and in zymosan-
stimulated H2O2 production in these cells. The relative
contribution of these receptors to yeast uptake depended on
the activation state of macrophages, with yeast uptake
being mediated largely by b-glucan receptors in untreated
macrophages and by SRs, but not b-glucan receptors, in
macrophages pre-exposed to a ligand of TLR9. Experi-
ments with the use of competitive ligands, transfected or
receptor-deﬁcient cells allowed us to identify SR-A as one
of SRs responsible for uptake of zymosan, but not of live
C. albicans yeasts, and MARCO as a receptor contributing
to uptake of both C. albicans and zymosan in CpG-ODN-
pre-treated, but not untreated macrophages.
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